Accuray reported $71.79M in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US USD 4.59B 36M
Accuray ARAY:US USD 71.79M 9.9M
Angiodynamics ANGO:US USD 40.35M 1.12M
Atricure ATRC:US USD 21.53M 523K
Boston Scientific BSX:US USD 1.02B 54M
Cardiovascular Systems CSII:US USD 16.7M 429K
Cryolife CRY:US USD 28.09M 74K
Edwards Lifesciences EW:US USD 257.9M 5.7M
Hologic HOLX:US USD 456.3M 26M
Inogen INGN:US USD 62.59M 5.47M
Mesa Laboratories MLAB:US USD 22.36M 3.25M
Orthofix International OFIX:US USD 30.57M 1.03M
Surmodics SRDX:US USD 5.6M 456K
Tandem Diabetes Care TNDM:US USD 100.12M 1.81M